Additionally, minor differences in relative rates of improvement in the SNOT-22 were seen at 0.88 and 0.83 for the Initial TPS ≤ 4 and Initial TPS ≥ 5 groups respectively, which also did not reach statistical significance ( P = 0.07) (Fig. 3 C and Table 3 ).
← all excerpts
The "real life" efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP.
1
0.0700
0.0700